CVS Health Corporation

CVS Health Corporation

CVSNYSE / NASDAQHealthcareLarge cap

$80.84+$0.80 (+1.0%)

Last close · Data as of Nov 20, 2026

Market cap
$121.0B
P/E
68.4x
EV / EBITDA
19.5x
Revenue
$402.1B
Net margin
0.4%
ROCE
6.3%

+6.3% over the last year

CVS Health Corporation price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-14.7%
3M
-13.7%
6M
-13.3%
1Y
+6.3%
5Y
-13.2%

52-week range

Day change +$0.80 (+1.0%) from $80 to $81 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in CVS, bought on each weekday since 2021.

News & filings

What CVS Health filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthFree cash flow was 4.42 times net profit in fiscal 2025.

Concerns (1)

  • Return on equity of 2.4% against a peer median of 12.1%.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments.

Read moreShow less

CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPS, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Sector
Healthcare
Shares outstanding
1.26B

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$121.0B
P/E
68.4x
P/B
1.6x
EV / EBITDA
19.5x
EV / Sales
0.5x
P/S
0.3x
52-week high
$110.60
52-week low
$70.08

Profitability

Operating margin
2.6%
Net margin
0.4%
EBITDA margin
2.5%
ROE
2.4%
ROCE
6.3%
ROA
0.7%
Asset turnover
1.59

Growth

Revenue
$402.1B
Revenue growth, 1Y
7.8%
Revenue CAGR, 3Y
7.6%
Net profit growth, 1Y
-61.7%
Free cash flow
$7.8B

Solvency

Current ratio
0.84
Debt / Equity
1.06
Debt / Assets
0.32
CFO / Net profit
6.02
Cash / Market cap
7.0%

Where the revenue went

Of every $100 of FY2025 revenue, $0 was left as net income.

CVS Health Corporation income statement flow, FY2025
CVS Health Corporation income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$346.7B
RevenueGross profit$55.4B
Gross profitOperating expenses$45.0B
Gross profitOperating income$10.4B
Operating incomePretax income$2.1B
Operating incomeInterest and other expense$8.2B
Pretax incomeTax and other$368.0M
Pretax incomeNet income$1.8B

Revenue and net profit

Revenue grew 7.8% in FY2025; net profit is the dashed line.

CVS Health Corporation revenue and net profit by fiscal year
CVS Health Corporation revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$322.5B$4.3B
FY2023$357.8B$8.3B
FY2024$372.8B$4.6B
FY2025$402.1B$1.8B

Cash flows

FY2025: $10.6B from operations, $7.8B free after investment (dashed).

CVS Health Corporation operating and free cash flow by fiscal year
CVS Health Corporation operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$16.2B$13.4B
FY2023$13.4B$10.4B
FY2024$9.1B$6.3B
FY2025$10.6B$7.8B

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$402.1B+7.8%1Y
EBITDA
$9.9B-28.0%1Y
Net profit
$1.8B-61.7%1Y
Cash from operations
$10.6B+16.8%1Y
Free cash flow
$7.8B+23.4%1Y
Revenue CAGR, 3Y
7.6%
Net profit CAGR, 3Y
-25.7%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$402.1B$9.9B$1.8B$7.8B2.4%+7.8%-61.7%

Monthly returns

Month-by-month returns of CVS across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$253.5B
Liabilities$178.2B
Equity$75.4B
Retained earnings$61.2B
Treasury stock$36.8B
Minority interest$168.0M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; CVS highlighted.

P/E against peers

CVS trades at 68.4x earnings against a peer median of 25.5x (a 169% premium).

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
CVS Health CorporationCVSthis companyP/E ↑ premium$121.0B68.4x1.6x2.4%19.5x
Intuitive Surgical, Inc.ISRG$148.3B51.9x8.3x16.0%39.3x
Pfizer Inc.PFE$146.4B18.8x1.7x9.0%12.5x
Danaher CorporationDHR$132.1B36.6x2.5x6.9%21.2x
Bristol-Myers Squibb CompanyBMY$115.6B16.4x6.3x38.2%10.0x
Stryker CorporationSYK$115.5B35.6x5.2x14.5%20.2x
Vertex Pharmaceuticals IncorporatedVRTX$112.1B28.4x6.0x21.2%22.4x
Medtronic plcMDT$105.2B22.6x2.2x9.7%14.3x
McKesson CorporationMCK$91.0B19.1x-41.9x-219.2%13.3x
Peer median—25.5x3.8x12.1%17.2x

Year-to-date ROI

CVS since 1 January, against earlier years.

Historical volatility

CVS's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

CVS Health Corporation operating margin by fiscal year
CVS Health Corporation operating margin by fiscal year
DateOperating margin
FY20225.1%
FY20234.1%
FY20242.6%
FY20252.6%
LineFY2025
Cost of revenueCost Of Revenue$346.7B
Gross profitGross Profit$55.4B
Operating expensesOperating Expense$45.0B
Other operating expensesOther Operating Expenses$45.0B
Total expensesTotal Expenses$391.7B
Pretax incomePretax Income$2.1B

Learn while you research

Academy chapters picked for CVS Health Corporation and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Valuation Multiples ExplainedThis stock trades at a P/E of 68.4, learn when high multiples are justified.6 min read
  3. 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →